Breaking Finance News

Humana Inc (NYSE:HUM) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.

Zacks Investment Research has downgraded Humana Inc (NYSE:HUM) to Hold in a statement released on 05/23/2017.

On 05/18/2017, Zacks Investment Research released a statement about Humana Inc (NYSE:HUM) upped the target price from $0.00 to $253.00 that suggested an upside of 0.12%.

Having a price of $228.52, Humana Inc (NYSE:HUM) traded -1.28% lower on the day. With the last stock price down 7.41% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.01% over the same period. HUM has recorded a 50-day average of $244.96 and a two hundred day average of $238.02. Trade Volume was up over the average, with 1,374,098 shares of HUM changing hands over the typical 1,077,400

Recent Performance Chart

Humana Inc (NYSE:HUM)

Humana Inc has PE ratio of 21.03 with a one year low of $165.03 and a one year high of $264.56 and has a market capitalization of $0.

A total of 15 brokerages have issued a ratings update on Humana Inc. Three brokerages rating the company a strong buy, three brokerages rating the company a buy, thirteen brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero brokerages rating the company a sell with a 12-month price target of $205.93.

General Company Details For Humana Inc (NYSE:HUM)

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *